Could Statins Ease Deadly Heart Condition in Rare Neuromuscular Disease?

PHILADELPHIA – In preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich’s ataxia (FA), a widely used cholesterol-lowering drug increased a precursor of HDL (high-density lipoprotein), the “good cholesterol,” according to new research published in PLOS One from the Perelman School of Medicine at the University of Pennsylvania.